Atlas Trials

Arabinoxylan-oligosaccharides (AXOS) for the Management of Type-2 Diabetes

Clinical trial NCT05689684 · COMPLETED

Trial details

NCT number
NCT05689684
Sponsor
Lund University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes Type 2
Start date
2022-11-07
Primary completion
2023-10-06
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.